Axim Biotechnologies, Inc. (AXIM): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

245.93M

As of 2023-12-31

+25.2%

3-year compound annual growth

2010-12-31 Shares Outstanding (shares) 2023-12-31

Period ended	Shares Outstanding	Change YoY	Source filing
2023-12-31	245.93M	+27.8%	2024-04-16, Balance as of period end
2022-12-31	192.44M	+39.3%	2024-04-16, Balance as of period end
2021-12-31	138.10M	+10.2%	2023-04-17, Balance as of period end
2020-12-31	125.33M	n/c	2022-04-19, Balance as of period end
2019-12-31	64.85M	+8.8%	2021-04-26, Balance as of period end
2018-12-31	59.58M	+9.2%	2020-05-20, Balance as of period end
2017-12-31	54.56M	+3.9%	2019-04-08, Balance as of period end
2016-12-31	52.51M	+32.5%	2018-03-15, Balance as of period end
2015-12-31	39.63M	+20.1%	2017-09-14, Balance as of period end
2014-12-31	33.00M	0.0%	2016-04-18, Balance as of period end
2013-12-31	33.00M	0.0%	2015-04-14, Balance as of period end
2012-12-31	33.00M	0.0%	2014-03-04, Balance as of period end
2011-12-31	33.00M	n/c	2013-04-15, Balance as of period end
2010-12-31	20.00M	n/a	2012-05-01, Balance as of period end